Low Blood Sugar Alerts
How to Spot Low Blood Sugar & Nighttime Lows Early with CGM Alerts
By GlucoRx Editorial Team · Last updated 14 September 2026
Low blood sugar (hypoglycaemia) is generally a glucose reading below 70 mg/dL (3.9 mmol/L) according to the American Diabetes Association; Diabetes UK describes a hypo as usually below 4 mmol/L. A continuous glucose monitor (CGM) tracks your glucose day and night and can alert you when it detects your glucose falling below a level you set — including while you sleep. Nighttime lows are easy to miss because you are asleep, so a low-glucose alert is designed to notify you so you can check and act.
A CGM is a monitoring aid, not a treatment. It does not prevent or treat low blood sugar. If you experience low blood sugar, follow your doctor's advice and treatment plan. Individual results vary, and this page is not a substitute for medical advice.
What is low blood sugar (hypoglycaemia)?
Hypoglycaemia means your blood glucose has dropped too low. The American Diabetes Association defines it in levels based on how low the reading is:
- Level 1: glucose below 70 mg/dL (3.9 mmol/L) but at or above 54 mg/dL (3.0 mmol/L).
- Level 2: glucose below 54 mg/dL (3.0 mmol/L).
- Level 3: a severe event involving altered mental or physical status that needs another person's help.
Why are nighttime lows easy to miss?
A nighttime (nocturnal) low is a hypo that happens overnight, while you are asleep. The threshold is the same as during the day — below 70 mg/dL (3.9 mmol/L), or below 4 mmol/L as Diabetes UK describes it — but because you are asleep you may not notice the usual warning signs.
In studies of people with type 1 diabetes, a large proportion of severe hypoglycaemia — around half — occurs overnight, and many nighttime lows are not felt. In the DCCT, roughly 55% of severe episodes happened at night. These figures come from type 1 diabetes research and describe groups of people studied, not any one individual.
This is one reason a CGM can help: the American Diabetes Association notes that CGM can reveal asymptomatic hypoglycaemia — lows you did not feel — and help you and your care team identify overnight patterns.
How do CGM low-glucose alerts work?
A continuous glucose monitor tracks your glucose day and night and can alert you when it detects your glucose falling below a level you set — including while you sleep. The GlucoRx Vixxa 2, for example, takes a reading every 60 seconds (about 1,440 a day) and sends the data to your phone.
According to the American Diabetes Association, real-time CGM can provide alarms that warn people of falling glucose so they can intervene, and it can help identify patterns and precipitants. In clinical trials, CGM use has been associated with lower rates of hypoglycaemia across the groups studied — this is population-level research evidence, not a promise about any one person's results.
There are two broad kinds of low alert. A threshold alert notifies you when your glucose crosses a number you have set. A predictive alert warns you before you reach it — for example, Dexcom's “Urgent Low Soon” alert warns when your glucose is predicted to reach 55 mg/dL (3.1 mmol/L) within 20 minutes. Predictive alerts are an established CGM feature offered by several systems.
Remember: a CGM is a monitoring aid, not a treatment. It does not prevent or treat low blood sugar. If you experience low blood sugar, follow your doctor's advice and treatment plan.
How do you set up low-glucose alerts?
On many CGMs alerts are optional and must be switched on. General steps for setting up low-glucose alerts:
- Agree a low threshold with your doctor or diabetes team — for example a level around 70 mg/dL (3.9 mmol/L) or 4 mmol/L — based on your treatment plan.
- Turn the low alert on in your CGM app; on many systems alerts are off by default.
- Keep alerts enabled overnight so you can be notified of a nighttime low while you sleep.
- Check your phone's volume, “do not disturb” and notification settings so an overnight alert can actually wake you.
- Review your overnight readings and patterns with your care team, and adjust your settings on their advice.
Which alert features does the Vixxa 2 have?
The GlucoRx Vixxa 2 offers customisable threshold high and low alerts only. It does not have a predictive “urgent low soon” alert, and it does not offer caregiver or follower sharing.
Predictive alerts and caregiver sharing are found on other systems. Dexcom offers the predictive “Urgent Low Soon” alert, and Dexcom Follow lets you share readings and alerts with up to 10 followers. Abbott's LibreLinkUp lets you share with up to 20 caregivers. If sharing alerts with a family member or carer matters to you, look at systems that document that feature.
Whichever system you use, a CGM is a monitoring aid, not a treatment. It does not prevent or treat low blood sugar. If you experience low blood sugar, follow your doctor's advice and treatment plan.
When should you get medical advice?
Set your thresholds and alert settings with your doctor or diabetes care team, and follow the plan you agree for what to do when you get a low alert.
Because a CGM measures glucose in the fluid just under your skin rather than in blood, its reading can lag your blood glucose by around 5–15 minutes. Clinical guidance — for example from the NHS — advises doing a finger-prick blood glucose check before treating a suspected low or making a treatment decision.
NICE guidance (NG17) says adults with type 1 diabetes should be offered a choice of real-time or flash CGM, and lists the fear, frequency, awareness and severity of hypoglycaemia among the factors to consider. This is guidance for clinicians, not a product claim.
The Vixxa 2 is indicated for adults (18 years and older) and is licensed for import in India under the Medical Device Rules 2017 (CDSCO import licence IMP/MD/2025/000209). A CGM is a monitoring aid, not a treatment. It does not prevent or treat low blood sugar. If you experience low blood sugar, follow your doctor's advice and treatment plan. Individual results vary, and this page is not a substitute for medical advice.
Frequently Asked Questions
At what level is blood sugar considered low (hypoglycaemia)?
The American Diabetes Association defines Level 1 hypoglycaemia as glucose below 70 mg/dL (3.9 mmol/L), Level 2 as below 54 mg/dL (3.0 mmol/L), and Level 3 as a severe event needing another person's help. Diabetes UK describes a hypo as usually below 4 mmol/L. Any reading below 70 mg/dL is clinically important, whether or not you feel symptoms — follow your doctor's advice.
Can a CGM alert me to low blood sugar at night?
A CGM tracks your glucose day and night and can alert you when it detects your glucose falling below a level you set, including while you sleep. Nighttime lows are easy to miss because you are asleep. A CGM is a monitoring aid, not a treatment — it does not prevent or treat low blood sugar, so follow your doctor's advice and treatment plan.
Does the GlucoRx Vixxa 2 have predictive alerts or caregiver sharing?
No. The Vixxa 2 offers customisable threshold high and low alerts only. It does not have a predictive “urgent low soon” alert or caregiver/follower sharing. Those features are found on other systems — for example Dexcom (Urgent Low Soon; and Dexcom Follow, up to 10 followers) and Abbott (LibreLinkUp, up to 20 caregivers).
Should I still do a finger-prick if my CGM alerts me to a low?
Clinical guidance, for example from the NHS, advises a confirmatory finger-prick blood glucose check before treating a suspected low or making a treatment decision. A CGM measures interstitial fluid, which can lag blood glucose by around 5–15 minutes. Follow your doctor's treatment plan.
Important information & sources
AI-assisted content. This page was created with the help of AI and public sources, and reviewed against them, as of 14 September 2026. Details may change — please verify current specifications and prices with the manufacturer or an authorised seller before you rely on them.
This page is published by GlucoRx, the manufacturer of the Vixxa 2 sensor. It is for general information only and is not medical advice. Individual results vary. Consult your doctor or diabetes care specialist before making changes to your monitoring or treatment.
Definitions, thresholds and guidance were retrieved in September 2026 from the sources below. Hypoglycaemia thresholds follow the American Diabetes Association and Diabetes UK; overnight-hypoglycaemia frequency figures come from type 1 diabetes research (including the DCCT) and describe groups studied, not any individual. Predictive alerts and caregiver sharing are described for the Dexcom and Abbott systems and are not features of the GlucoRx Vixxa 2, which offers customisable threshold high/low alerts only. The Vixxa 2 is indicated for adults (18+) and is licensed for import in India under CDSCO import licence IMP/MD/2025/000209.
All trademarks are the property of their respective owners. Dexcom and Dexcom Follow are trademarks of Dexcom, Inc.; FreeStyle Libre and LibreLinkUp are trademarks of Abbott. If you spot an error on this page, please email info@glucorx.co.in and we will correct it promptly.
Sources
- ADA Standards of Care (2024) — Glycemic Goals & Hypoglycemia (§6)
- Diabetes UK — Hypos (low blood sugar)
- Nocturnal hypoglycaemia — review (incl. DCCT epidemiology)
- Berry et al., 2025 — predictive CGM low-glucose alerts
- Dexcom Follow — caregiver sharing
- Abbott LibreLinkUp — caregiver sharing
- NICE NG17 — Type 1 diabetes in adults: diagnosis and management
- NHS — My Diabetes My Way: continuous glucose monitoring
- GlucoRx Vixxa 2 — product information & FAQ
- GlucoRx Vixxa 2 — Pricing
Track your glucose day and night with Vixxa 2
CDSCO-licensed. 15-day wear. IP68 waterproof. Free shipping across India.